Latest Transatlantic Law International European M&A Deal Closes – In Biotech
Transatlantic Law International (TALI), with its Swiss affiliate, Vischer, has recently assisted JSR Corporation, the leading Tokyo Stock Exchange listed biotech company in its acquisition of Selexis SA, a pioneering life sciences company and global leader in mammalian cell-line generation technologies based in Switzerland, which closed on June 21, 2017.
JSR Corporation, through its business unit JSR Life Sciences, provides specialized materials and products to the biotech industry. JSR Life Sciences operates a network of manufacturing facilities, sales offices and R&D labs in key markets throughout North America, Europe and Asia-Pacific. JSR Life Sciences is focused on diagnostics and research products and bioprocessing materials and services for the manufacture of biologics.
TALI’s M&A practice spans multiple industries worldwide, with the firm regularly completing major regional and single country transactions as well as multi continental transactions.
Read the press release here: